Occurrence of Neuropsychiatric Symptoms at Low Levels of Occupational Exposure to Organic Solvents and Relationships to Health, Lifestyle, and Stress

References

• Breitbart W, Bruera E, Chochinov H, Lynch M. Neuropsychiatric syndromes and psychological symptoms in patients with advanced cancer. J Pain Symptom Manage. 1995; 10: 131–41.
   PubMed Web of Science ®Google Scholar
• Brown TM, Brown EL. Neuropsychiatric consequences of renal failure. Psychosomatics. 1995; 36: 244–53.
   PubMed Web of Science ®Google Scholar
• Haggerty3, Garbutt JC, Evans DL, et al. Subclinical hypothyroi-didsm: a review of neuropsychiatric aspects. IntJ Psychiat Med. 1990; 20: 193-208.
   Google Scholar
• Hudgel DW. Neuropsychiatric manifestations of obstructive sleep apnea: a review. Int J Psychiatr Med. 1989; 19: 11–12.
   PubMed Web of Science ®Google Scholar
• Fallon BA, Nields JA, Burroscano B, Liegner K, DelBene D. Liebowitz MR. The neuropsychiatric manifestations of Lyme bor-reliosis. Psychiatr Q. 1992; 63: 95–117.
   PubMedGoogle Scholar
• McAllister TW. Neuropsychiatric sequelae of head injuries. Psy-chiatr Clin North Am. 1992; 15: 395–413.
   PubMed Web of Science ®Google Scholar
• Gorman DF, Clayton D, Gilligan JE, Webb RE. A longitudinal study of 100 consecutive admissions for carbon monoxide poi-soning to the Royal Adelaide Hospital. Anaesth Intens Care. 1992; 20: 311–6.
   PubMed Web of Science ®Google Scholar
• Palmer KJ, Holliday SM, Brogden RN. Mefloquine. A review of its antimalarial activity, phannacokinetic properties and therapeuti-cal efficacy. Drugs. 1993; 45: 430–75.
   Google Scholar
• Gelder M, Gath D, Mayou R. Oxford Textbook of Psychiatry. Ox-ford, England: Oxford University Press, 1989: 161-3,175-9.
   Google Scholar
• Simon GE. Psychiatric symptoms in multiple chemical sensitivity. Tmticol Ind Health. 1994; 10: 487–96.
   PubMed Web of Science ®Google Scholar
• Farrar DJ, Locke SE, Kantrowitz FG. Chronic fatigue syndrome. 1: Etiology and pathogenesis. Behav Med. 1995; 21: 5–16.
   Google Scholar
• Bolla KI, Roca R. Neuropsychiatric sequaelae of occupational ex-posure to neurotmtins. In: Bleecker ML (ed). Occupational Neu-rology and Clinical Neurotoxicology. Baltimore, MD: Williams & Wilkins, 1994.
   Google Scholar
• Baker EL. A review of recent research on health effects of human occupational exposure to organic solvents. J Occup Med. 1994; 36: 1079–92.
   PubMedGoogle Scholar
• Axelson O, Hogstedt C. The health effects of solvents. In: Zenz C, Dickerson OB, Horvath EP Jr (eds). Occupational Medicine. 3rd ed. St. Louis, MO: Mosby-Year Book, 1994.
   Google Scholar
• Lundberg I, Hogberg M, Michélsen H, Nise G, Hogstedt C. An evaluation of the questionnaire 16 (Q16) on neurotoxic symp-toms. 25th International Congress on Occupational Health. Book of Abstracts, Part II. Solna, Sweden: National Institute for Work-ing Life, 1996;213.
   Google Scholar
• Hogstedt C, Hane M, Agrell A, Bodin L. Neuropsychological test results and symptoms among workers with well-defined long-term exposure to lead. Br J Ind Med. 1983; 40: 99–105.
   PubMedGoogle Scholar
• Edling C, Anundi H, Johansson G, Nilsson K. Increase in neuropsychiatric symptoms after occupational exposure to low levels of styrene. Br J Ind Med. 1993; 50: 843–50.
   PubMedGoogle Scholar
• Kilburn KH. Neurobehavioral impairment and seizures from formaldehyde. Arch Environ Health. 1994; 49: 37–44.
   PubMed Web of Science ®Google Scholar
• Rodezno RA, Lundberg I, Escalona E. Development of a ques-tionnaire in Spanish on neurotoxic symptoms. Am J Ind Med. 1995; 28: 505–20.
   PubMed Web of Science ®Google Scholar
• Statistics Sweden. Occupations in Population and Housing Cen-sus 1985 (FoB 85) according to Nordic standard occupational classification (Nordisk yrkesklassificering, NYK) and Swedish so-cio-economic classification (Socioekonomisk indelning, SET). Al-phabetical version. Reports on Statistical Coordination 1989:5. Stockholm, Sweden; Statistics Sweden, 1989.
   Google Scholar
• Norbäck D, Edling C. Environmental, occupational, and personal factors related to the prevalence of sick building syndrome in the general population. Br J Ind Med. 1991; 48: 451–62.
   PubMedGoogle Scholar
• Anshelm Olson B. Effects of organic solvents on behavioural per-formance of workers in the paint industry. Neurobehav Toxicol Teratol. 1982; 4: 703–8.
   PubMedGoogle Scholar
• Edling C, Ekberg K. No acute behavioural effects of exposure to styrene: a safe level of exposure? Br J Ind Med. 1985; 42: 301–4.
   Google Scholar
• Rogier C, Dabis F, Teissier JF, Salamon K. Quel reolejouent le tabag-isme et la climatisation dans la survenue de symptomes oto-rhino-laryngologiques et respiratoires hauts chez le personnel d'un cen-tre hospitafier? [What roles do smoking and air conditioning play in the occurrence of sick building syndrome among hospital per-sonnel?] Rev. Epidémiol et Santé Publ. 1989; 37: 255–62.
   PubMedGoogle Scholar
• Skov P, Valbjørn O, Pedersen BY, the Danish Indoor Climate Study Group. Influence of personal characteristics, job-related factors and psychosocial factors on the sick building syndrome. Scand J Work Environ Health. 1989; 15: 286–95.
   Google Scholar
• Norback D, Torgén M, Edling C. Volatile organic compounds, respirable dust, and personal factors related to prevalence and in-cidence of sick building syndrome in primary schools. Br J Ind Med. 1990; 47: 733–41.
   PubMedGoogle Scholar
• WHO. Organic Solvents and the Central Nervous System, Envi-ronmental Health 1985;5. Copenhagen, Denmark, and Oslo, Norway: World Health Organization and Nordic Council of Min-isters, 1985.
   Google Scholar
• Dennis KE, Froman D, Morrison AS, Holmes KD, Howes DG. Beta-blocker therapy: identification and management of side ef-fects. Heart Lung. 1991; 20: 459–63.
   PubMed Web of Science ®Google Scholar